Studying tumor genes and life factors in adults with meningioma
Looks at how health risks and social conditions relate to meningioma in adults.
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 16 Jan 2026
- Expected to end
- 1 Jan 2032
- Type of study
- Observational
- Treatments tested
- Questionnaire
- Medical Record Review
- Record updated
- 19 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults diagnosed with a meningioma, a common brain tumor. Participants fill in a one-time survey of about 20 minutes, and their medical records are reviewed.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Any diagnosed meningioma
Main reasons for not taking part
- Active psychiatric issues, such as suicidal thoughts, active psychosis or grave disability
- Cannot give consent because of a severe brain or nerve problem or psychiatric distress
- Cannot complete the survey because of a severe brain or nerve problem or psychiatric distress
- Cannot speak and read English
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adults ≥18 years of age
- Able to speak and read English
- Diagnosed with a meningioma
Who cannot take part
- Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)
- Inability to consent secondary to severe neurologic deficit or psychiatric distress
- Inability to complete survey secondary to severe neurologic deficit or psychiatric distress
Where in United States
- University of California San FranciscoSan Francisco, United StatesContact: Zora ArumTaking people
About the trial
What the trial wants to find out
Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
The group in the trial
- Participants with Meningioma
Adult patients who have been diagnosed with a meningioma will be asked to complete a one-time survey, which will take roughly 20 minutes to complete. Participants will also have medical records reviewed to capture additional data relating to the participants medical history.
Treatment: Questionnaire and Medical Record Review
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- An Investigation of Tumor Genomics, Individual Risk Factors, and External Drivers of Health to Improve Health Outcomes for Patients With Meningioma
- Plain-language title
- Studying tumor genes and life factors in adults with meningiomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 19 May 2026